Metra Biosystems

Metra Biosystems is a biotechnology startup founded in 1990 with a mission to offer innovative diagnostic solutions for managing bone and joint health. The company specializes in developing and commercializing diagnostic products for the detection and management of metabolic bone and joint diseases and disorders. In February 1992, Metra Biosystems secured a Venture Round investment from notable investors including Avalon Ventures, Alpha Partners, DelphiBioVentures, and Asset Management Company. This funding supports the company's efforts to further develop and bring to market their cutting-edge solutions for diagnosing and managing bone and joint-related health issues. Operating within the Biotechnology and Health Care industries, Metra Biosystems is well-positioned to address the growing demand for advanced diagnostic tools in the healthcare sector. With a strong investor backing and a clear focus on innovation, the company has the potential to make significant strides in improving the diagnosis and management of metabolic bone and joint diseases.